Kimberly Manhard, Director at HERON THERAPEUTICS, INC. /DE/ (HRTX), sold 13,208 shares at $23.58 ($305K) on 2015-06-02, disclosed to the SEC on 2015-06-03.
Open-market sale of $305k HRTX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.17 | 2,708 | $57K | 18.8% |
| 2 | $23.58 | 10,500 | $248K | 81.2% |
| Total | $23.09 avg | 13,208 | $305K | 100% |
| Filing → |
| INBX | BUY | 2024-08-30 | $140K | — | Filing → |
| HRTX | SELL | 2022-05-04 | $7K | — | Filing → |
| HRTX | SELL | 2021-05-04 | $27K | — | Filing → |